Differing Clinical Presentations of Fusobacterium necrophorum Bacteremia in Female vs Male Individuals: A Case Series Authors: Judith Ratcliffe, Alex Pelliccione, Caitlin Otto, Christopher Kerantzas, Madeline A DiLorenzo, Wesley Rogers Published: 2026 ABSTRACT AbstractThis case series reviews individuals with Fusobacterium necrophorum bacteremia at a New York City hospital from 1 December 2014 through 1 December 2024. Sex-based differences in clinical manifestations were observed; female patients presented with genital tract infections. Consequently, F necrophorum bacteremia in female patients should prompt evaluation of the genital tract. BACKGROUND Fusobacterium necrophorum is an obligate anaerobic Gram-negative rod thought to be commensal flora of the oral, gastrointestinal, and female genital tract. A defining pathogenic mechanism of F necrophorum is its ability to cause thrombosis [1], particularly septic thrombophlebitis of the internal jugular vein (Lemierre syndrome), and pulmonary septic emboli [1]. It can also lead to complications such as bacteremia, and frequently affects young, otherwise healthy individuals [1,2] . Although F necrophorum is traditionally associated with Lemierre syndrome, it has long been recognized as a potential commensal of the female genital tract. Nevertheless, infections associated with the female genital tract are uncommon, with limited reports in the literature. Two case reports describe young, otherwise healthy patients assigned female sex at birth who each were found to have F necrophorum bacteremia associated with genital infections. One patient presented with a febrile illness and respiratory distress and was found to have vaginal edema and abnormal discharge with rapid progression to septic shock [3]. Another presented after recent sexual intercourse with acute respiratory failure and was found to have left internal iliac vein thrombosis with pulmonary embolus [4]. A separate case series examined 2 female patients with F necrophorum bacteremia in the setting of recent vaginal delivery [5]. This latter series proposed that, although there is limited literature on the subject, disruptions in the vaginal microbiome can lead to invasive infection, particularly when considering mucosal barrier disruptions such as those seen in childbirth [5]. Given the complexity and variability in clinical manifestations of invasive F necrophorum infection, we sought to review all patients diagnosed with F necrophorum bacteremia over a 10-year period at a single hospital in New York City. METHODS An institutional review board protocol was approved (protocol s25-00157) and a retrospective chart review conducted of all patients found to have F necrophorum bacteremia in the microbiology laboratory database at New York University Langone Hospital in New York City from 1 December 2014 through 1 December 2024. The data were collected via EPIC, the electronic medical record used by New York University Langone Hospital. Individual patient charts were examined and data deidentified. Descriptive analysis was performed of qualitative variables. RESULTS Thirteen patients were identified, of which 62% (N = 8) were male (Table 1). More than half of the patients were younger than 30 years old at the time of diagnosis (N = 8, 62%) and had no prior medical history (N = 8, 62%). Four patients (31%) had dental disease and 1 patient (8%) had type 2 diabetes mellitus. No patients in the cohort were known to have HIV-1; 10 of the 13 patients (77%) had confirmed negative HIV testing within the electronic medical record. Table 1.Demographics, Comorbidities, Clinical Manifestations, and Outcomes in Patients With F necrophorum BacteremiaMale Patients (n = 8)Female Patients (n = 5)Age 20 y old or less2 (25%)2 (40%) Between 20 and 30 y of age2 (25%)2 (40%) Older than 30 y old4 (50%)1 (20%)ComorbiditiesNo medical history5 (63%)3 (60%)Hypertension3 (38%)0 (0%)Type 2 diabetes mellitus1 (13%)0 (0%)Other2 (25%)1 (20%)Abdominal pathologya2 (25%)0 (0%)Dental diseaseb3 (38%)1 (20%)HIV status…… Negative6 (75%)4 (80%) Unknown2 (25%)1 (20%)Specific gynecologic or obstetric historyPostpartumN/A2 (40%)Bartholin cystN/A1 (20%)Abnormal uterine bleedingN/A1 (20%)Clinical presentationFever7 (88%)5 (100%)Sore throat/mouth pain3 (38%)1 (20%)Headache2 (25%)0 (0%)Abdominal pain1 (13%)0 (0%)Knee pain following mechanical fall1 (13%)0 (0%)Postpartum feverN/A2 (40%)Rigors following I&D of Bartholin cystN/A1 (20%)Presumed etiology of bacteremiaDental/pharyngitis3 (38%)1 (20%)Sinusitis1 (13%)0 (0%)Intraabdominal…… Septic thrombophlebitis of portal vein1 (13%)0 (0%) Perforated gallbladder1 (13%)0 (0%)Unknown2 (25%)0 (0%)Genital tract source0 (0%)4 (80%)Features of bacteremiaGreater than 1 bottle positive6 (75%)4 (80%)Sustained bacteremia (detected on subsequent days)1 (13%)1 (20%)Polymicrobial bacteremia4 (50%)0 (0%)Isolate susceptible to penicillin7 (88%)5 (100%)Isolate susceptible to metronidazole7 (88%)5 (100%)ComplicationsHypopharynx abscess1 (13%)0 (0%)Subgaleal abscess1 (13%)0 (0%)Hepatic abscess1 (13%)0 (0%)Septic arthritis1 (13%)0 (0%)Septic emboli1 (13%)1 (20%)Parapneumonic effusion1 (13%)1 (20%)Duration of antibioticsLess than 7 d2 (25%)0 (0%)Between 7 d and 2 wks1 (13%)3 (60%)Greater than 2 wks5 (63%)2 (40%)Presence of ID consult5 (63%)5 (100%)Abbreviations: I&D, incision and drainage; ID, infectious disease; N/A, not applicable. aCholedocholithiasis, diverticulitis. bIncludes edentulous. Demographics, Comorbidities, Clinical Manifestations, and Outcomes in Patients With F necrophorum Bacteremia Abbreviations: I&D, incision and drainage; ID, infectious disease; N/A, not applicable. aCholedocholithiasis, diverticulitis. bIncludes edentulous. Regarding clinical manifestations (Table 1), 93% (N = 12) of patients presented with fever, whereas other manifestations relating to the site of infection, or a complication thereof, included sore throat/mouth pain (N = 4), abdominal pain (N = 1), and chest pain (N = 1). Among the 5 female patients, 80% (N = 4) had manifestations attributed to female genital tract-related infection. Two of the patients presented with postpartum fever: the first developed fevers hours following spontaneous vaginal delivery with detectable bacteremia that same day, despite having had a normal external examination. The second patient developed fever 2 days after vaginal delivery with concurrent development of fundal tenderness, although she similarly had no signs of infection on external examination. A third female patient presented with fever and rigors after undergoing incision and drainage of a suspected superinfected Bartholin cyst, with external examination notable for labial swelling and a fluctuant collection. Cross-sectional imaging revealed a thick-walled, rim-enhancing abnormality at the vaginal introitus without alternative source of bacteremia. An elderly female patient with suspected uterine malignancy presented with recurrent vaginal bleeding. Her genital examination was notable for clots in the vaginal vault and her pelvic ultrasound revealed an endometrial mass with increased vascularity and cystic changes. She had sustained bacteremia with persistent bleeding episodes, suggestive of ongoing bacterial translocation from the genitourinary tract. Among the 13 patients, complications of F necrophorum bacteremia included hepatic abscess (N = 1), septic arthritis (N = 1), septic emboli (N = 2, thought to be related to Lemierre syndrome), parapneumonic effusion (N = 2), and subgaleal abscess (N = 1). In review of the microbiologic data, 85% (N = 11) of patients had only 1 day of detectable bacteremia. Polymicrobial bacteremia was seen in 31% (N = 4) of patients. All isolates with antimicrobial susceptibility testing showed susceptibility to penicillin and metronidazole. Seventy-seven percent (N = 10) of patients had formal infectious disease consultation during their course, with all female patients undergoing formal infectious disease consultation. The treatment for F necrophorum bacteremia ranged from 6 days to 8 weeks from the date of blood culture clearance, with longer duration in patients with complications of bacteremia. One patient died during hospitalization, although this was thought to be due to cardiogenic shock. Among the female patients, 40% (N = 2) required treatment beyond 2 weeks. DISCUSSION This case series sought to review the breadth of manifestations of F necrophorum bacteremia in a single institution in New York City. Our patient population was primarily younger than 30 years old without any known medical comorbidities. Prior studies have shown that F necrophorum has a predilection for young, healthy hosts [1, 2, 6]. A Finnish study of Fusobacterium species bacteremia found that patients with F necrophorum bacteremia were often healthy and less than 30 years old, whereas those with F nucleatum bacteremia, a less virulent species, were more likely to have chronic underlying disease [6]. In considering patient outcomes, a Denmark study examined mortality associated with Fusobacterium species infections and estimated a 6-month mortality of 32%. Notably, this was significantly related to increased age and malignancy but not related to individual Fusobacterium species [7]. Similarly, an Australian study examining Fusobacterium spp. bacteremia determined that increased 30-day all-cause case fatality was associated with increased age and presence of comorbidities, including malignancy [8]. These findings may account for the outcomes in our predominantly young and healthy cohort: no deaths were attributed to disease caused by F necrophorum. Both in our study and in published literature, Fusobacterium species such as F necrophorum are associated with diverse presentations and clinical syndromes, including head and neck infections, intra-abdominal infections, soft-tissue infections, and genitourinary infections, although the classic association is Lemierre syndrome [2, 3, 5, 6, 8]. Interestingly, there were differences in clinical presentations in our cohort based on sex; 80% (N = 4) of the female patients presented with infections associated with the female genitourinary tract, as opposed to oropharyngeal infections. In the aforementioned Finnish study, 6 individuals developed puerperal infections with Fusobacterium species bacteremia, though only 1 had bacteremia with F necrophorum. These patients were suspected to have chorioamnionitis from an ascending vaginal infection [6]. In the Australian study cited, which included 156 female patients, approximately one half of the total cohort had no identifiable focus of infection, reflective of the complexity in diagnosing the etiology of these infections [8]. In our cohort, 2 of the female patients developed infection following spontaneous vaginal deliveries. Both patients had rapid clearance of bacteremia and no metastatic complications of infection. Although there is a paucity of literature on F necrophorum and pelvic infections, proposed theories include disruptions in the vaginal microbiome leading to increased colonization of bacteria and progression to invasive infection. However, this has most strongly been asserted in the setting of placement of intrauterine devices [5]. Other considerations include the trauma of childbirth leading to disruptions in mucosal barrier and subsequent bacterial translocation [5]. Notably, 1 of our female patients developed superinfection of a Bartholin cyst requiring incision and drainage, with subsequent development of F necrophorum bacteremia. The association of Bartholin cyst and F necrophorum has been previously documented in a case report of a young woman who presented with similar symptoms and ultimately developed metastatic pulmonary and hepatic abscesses [9]. The presumed etiology in both settings was superinfection, with our patient demonstrating invasive infection with bacteremia but fortunately no metastatic complications. These presentations suggest the importance of consideration of predisposing gynecologic disease in those presenting with Fusobacterium bacteremia [5, 9]. Fusobacterium necrophorum bacteremia can lead to a wide manifestation of clinical syndromes. In this case series, we found an important difference in the manifestations among female patients when compared with male patients. Although the association with pelvic infections has been noted in prior case reports, it has not been highlighted in prior studies of bacteremia with Fusobacterium species as a whole. This raises the question of whether F necrophorum in particular has a predilection for invasive disease via the female genitourinary tract in young and otherwise healthy patients. CONCLUSION Fusobacterium necrophorum is a bacteria associated with multiple syndromes of infection, thought to be related to commensal flora in various locations in the body. Given the infrequent nature in which this disease is seen, and the rise in reports of F necrophorum infection in association with the female genital tract, the presence of F necrophorum bacteremia in a female patient should prompt consideration of a primary genitourinary tract infection. This case series demonstrates the variability in presentations of F necrophorum bacteremia and the importance of thoughtful diagnostic evaluation when it is detected.